Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carsten Bokemeyer

Showing results (121-130 of 663) with videos related to

Pageof 67
Sort By:
International Journal of Molecular Sciences|December 23, 2018
5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor CellsChristoph Oing, Izudin Verem, Wael Y Mansour, et al.
Anticancer Research|August 19, 2007
A phase II trial of weekly irinotecan in cisplatin-refractory esophageal cancerChristof Burkart, Carsten Bokemeyer, Bodo Klump, et al.
Cancer Chemotherapy and Pharmacology|December 8, 2010
Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatinKarin Holweger, Hans-Peter Lipp, Jos H Beijnen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 7, 2015
Severe and irreversible myelopathy after concurrent systemic and intrathecal nucleoside analogue treatment for refractory diffuse large B-cell lymphoma: A case report and review of the literatureWinfried H Alsdorf, Michael Schmitz, Aneta Schieferdecker, et al.
Annals of Hematology|November 16, 2022
VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experienceSusanne Ghandili, Dzenefa Alihodzic, Christian Wiessner, et al.
Emergency Medicine International|December 31, 2019
Challenges Faced by Prehospital Emergency Physicians Providing Emergency Care to Patients with Advanced Incurable DiseasesAnne Kamphausen, Hanna Roese, Karin Oechsle, et al.
Onkologie|May 9, 2006
Long-term survival after second-line therapy with docetaxel and carboplatin and monthly pamidronic acid in a woman with metastatic non-small cell lung cancerBirte Andritzky, Gunter Schuch, Ina Thoem, et al.
Death Studies|November 16, 2025
The trajectory of death anxiety in patients with advanced cancer and their family caregiversCharlotte Walbaum, Rebecca Philipp, Carsten Bokemeyer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2014
Peritumoral eosinophils predict recurrence in colorectal cancerLars Harbaum, Marion J Pollheimer, Peter Kornprat, et al.
Journal of Thrombosis and Haemostasis : JTH|September 1, 2020
Effect of myeloperoxidase on the anticoagulant activity of low molecular weight heparin and rivaroxaban in an in vitro tumor modelMinna Voigtlaender, Lennart Beckmann, Anita Schulenkorf, et al.
Pageof 67

Showing results (121-130 of 663) with videos related to

Sort By:
Pageof 67
International Journal of Molecular Sciences|December 23, 2018
5-Azacitidine Exerts Prolonged Pro-Apoptotic Effects and Overcomes Cisplatin-Resistance in Non-Seminomatous Germ Cell Tumor CellsChristoph Oing, Izudin Verem, Wael Y Mansour, et al.
Anticancer Research|August 19, 2007
A phase II trial of weekly irinotecan in cisplatin-refractory esophageal cancerChristof Burkart, Carsten Bokemeyer, Bodo Klump, et al.
Cancer Chemotherapy and Pharmacology|December 8, 2010
Evaluation of a non cystatin-C-based novel algorithm to calculate individual glomerular filtration rate in cancer patients receiving carboplatinKarin Holweger, Hans-Peter Lipp, Jos H Beijnen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|February 7, 2015
Severe and irreversible myelopathy after concurrent systemic and intrathecal nucleoside analogue treatment for refractory diffuse large B-cell lymphoma: A case report and review of the literatureWinfried H Alsdorf, Michael Schmitz, Aneta Schieferdecker, et al.
Annals of Hematology|November 16, 2022
VTd-PACE and VTd-PACE-like regimens are effective salvage therapies in difficult-to-treat relapsed/refractory multiple myeloma: a single-center experienceSusanne Ghandili, Dzenefa Alihodzic, Christian Wiessner, et al.
Emergency Medicine International|December 31, 2019
Challenges Faced by Prehospital Emergency Physicians Providing Emergency Care to Patients with Advanced Incurable DiseasesAnne Kamphausen, Hanna Roese, Karin Oechsle, et al.
Onkologie|May 9, 2006
Long-term survival after second-line therapy with docetaxel and carboplatin and monthly pamidronic acid in a woman with metastatic non-small cell lung cancerBirte Andritzky, Gunter Schuch, Ina Thoem, et al.
Death Studies|November 16, 2025
The trajectory of death anxiety in patients with advanced cancer and their family caregiversCharlotte Walbaum, Rebecca Philipp, Carsten Bokemeyer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 13, 2014
Peritumoral eosinophils predict recurrence in colorectal cancerLars Harbaum, Marion J Pollheimer, Peter Kornprat, et al.
Journal of Thrombosis and Haemostasis : JTH|September 1, 2020
Effect of myeloperoxidase on the anticoagulant activity of low molecular weight heparin and rivaroxaban in an in vitro tumor modelMinna Voigtlaender, Lennart Beckmann, Anita Schulenkorf, et al.
Pageof 67